NCT07297303Recruiting
Longitudinal Pulmonary Chronic Graft-versus-host-disease (GvHD) Assessment in Hematopoietic Stem Cell Transplantation (HSCT) Patients
Source: ClinicalTrials.gov · Last updated 22 Dec 2025
Brief summary (registry, in English)
Prospective observational study on the clinical characteristics of pulmonary graft-versus-host disease in patients after hematopoietic stem cell transplantation.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 600 (estimated)
- First submitted
- 9 Dec 2025
- Start date
- 30 Sept 2025
- Primary completion date
- 31 Dec 2030
- Lead sponsor
- National Taiwan University Hospital
- NCT number
- NCT07297303
What you commit to
- Study type: Observational
- Planned participants: 600
- From 30 Sept 2025 to the primary completion date, 31 Dec 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- The patient received lung transplantation before
Other illness
- Respiratory failure
- Pneumothorax or bronchial fistula
- Acute coronary syndrome in recent 1 month
Other
- Hemodynamic unstable
- The patient couldn't walk longer than 20 m
- Severe lower-limb arthropathy
- The patient couldn't cooperate well
- Need all-day oxygen supplement
Who the study is looking for
- Age\>18
- Will Receive first time Allo-HSCT patients
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Taiwan University Hospital Coordinator of this site? Confirm its status | Taipei | Taiwan | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.